FDA modified its labeling on February, 2009 to include a precaution of drug interaction with gold . " Nitritoid reactions ( symptoms include facial flushing, nausea, vomiting and hypotension ) have been reported rarely in patients on therapy with injectable gold ( sodium aurothiomalate ) and concomitant ACE inhibitor therapy including Monopril / Monopril HCT ."
मोबाइल